Cargando…
Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy?
BACKGROUND: Ultrasound-detected breast lesions with probably benign features are a great challenge for clinicians, especially in breasts with dense composition. We aimed to investigate the finding of two radiologic modalities on these lesions. METHODS: This retrospective cross-sectional study recrui...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823155/ https://www.ncbi.nlm.nih.gov/pubmed/36624818 http://dx.doi.org/10.1016/j.ejro.2022.100474 |
_version_ | 1784866093275283456 |
---|---|
author | Arian, Arvin Delazar, Sina Aghasi, Maryam Jahanbin, Behnaz Ahmadinejad, Nasrin |
author_facet | Arian, Arvin Delazar, Sina Aghasi, Maryam Jahanbin, Behnaz Ahmadinejad, Nasrin |
author_sort | Arian, Arvin |
collection | PubMed |
description | BACKGROUND: Ultrasound-detected breast lesions with probably benign features are a great challenge for clinicians, especially in breasts with dense composition. We aimed to investigate the finding of two radiologic modalities on these lesions. METHODS: This retrospective cross-sectional study recruited patients including (1) candidates of assisted reproductive therapy (ART), (2) patients with prior high-risk lesions, and (3) the “suspected” BIRADS-3 masses referring to masses that US BIRADS-3 was not compatible with the clinical breast exam. The degree of agreement in diagnosing BIRADS-3 lesions between two modalities of magnetic resonance imaging (MRI) and ultrasonography (US), and comparison of the lesions in US and MRI were the study variables. RESULTS: A total number of 123 lesions in 67 patients with a median age of 38 (IQR: 11, range: 17–67). In the examination by MRI, 107 (87.0 %) lesions were BIRADS-3 indicating the agreement level between these two modalities. The median size of the lesions in US was 9 mm (IQR: 5, range: 3–43) and 9 mm (IQR: 10, range: 4–46) in MRI. The measured size of the lesions between the two modalities was highly correlated (Spearman correlation coefficient: 0.889, P-value < 0.001). MRI evaluation revealed two cases of deep lesions which were missed in the US imaging. CONCLUSIONS: This study found relatively high agreement values between US and MRI in detecting BIRADS-3 breast lesions in candidates for ART or patients with prior high-risk lesions. Also, MRI could downgrade about one-tenth of the cases to a lower BIRADS level and resolved the need for closer follow-up. |
format | Online Article Text |
id | pubmed-9823155 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-98231552023-01-08 Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy? Arian, Arvin Delazar, Sina Aghasi, Maryam Jahanbin, Behnaz Ahmadinejad, Nasrin Eur J Radiol Open Original Article BACKGROUND: Ultrasound-detected breast lesions with probably benign features are a great challenge for clinicians, especially in breasts with dense composition. We aimed to investigate the finding of two radiologic modalities on these lesions. METHODS: This retrospective cross-sectional study recruited patients including (1) candidates of assisted reproductive therapy (ART), (2) patients with prior high-risk lesions, and (3) the “suspected” BIRADS-3 masses referring to masses that US BIRADS-3 was not compatible with the clinical breast exam. The degree of agreement in diagnosing BIRADS-3 lesions between two modalities of magnetic resonance imaging (MRI) and ultrasonography (US), and comparison of the lesions in US and MRI were the study variables. RESULTS: A total number of 123 lesions in 67 patients with a median age of 38 (IQR: 11, range: 17–67). In the examination by MRI, 107 (87.0 %) lesions were BIRADS-3 indicating the agreement level between these two modalities. The median size of the lesions in US was 9 mm (IQR: 5, range: 3–43) and 9 mm (IQR: 10, range: 4–46) in MRI. The measured size of the lesions between the two modalities was highly correlated (Spearman correlation coefficient: 0.889, P-value < 0.001). MRI evaluation revealed two cases of deep lesions which were missed in the US imaging. CONCLUSIONS: This study found relatively high agreement values between US and MRI in detecting BIRADS-3 breast lesions in candidates for ART or patients with prior high-risk lesions. Also, MRI could downgrade about one-tenth of the cases to a lower BIRADS level and resolved the need for closer follow-up. Elsevier 2022-12-30 /pmc/articles/PMC9823155/ /pubmed/36624818 http://dx.doi.org/10.1016/j.ejro.2022.100474 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Original Article Arian, Arvin Delazar, Sina Aghasi, Maryam Jahanbin, Behnaz Ahmadinejad, Nasrin Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy? |
title | Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy? |
title_full | Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy? |
title_fullStr | Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy? |
title_full_unstemmed | Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy? |
title_short | Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy? |
title_sort | does mri have added value in ultrasound-detected birads-3 breast masses in candidates for assisted reproductive therapy? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823155/ https://www.ncbi.nlm.nih.gov/pubmed/36624818 http://dx.doi.org/10.1016/j.ejro.2022.100474 |
work_keys_str_mv | AT arianarvin doesmrihaveaddedvalueinultrasounddetectedbirads3breastmassesincandidatesforassistedreproductivetherapy AT delazarsina doesmrihaveaddedvalueinultrasounddetectedbirads3breastmassesincandidatesforassistedreproductivetherapy AT aghasimaryam doesmrihaveaddedvalueinultrasounddetectedbirads3breastmassesincandidatesforassistedreproductivetherapy AT jahanbinbehnaz doesmrihaveaddedvalueinultrasounddetectedbirads3breastmassesincandidatesforassistedreproductivetherapy AT ahmadinejadnasrin doesmrihaveaddedvalueinultrasounddetectedbirads3breastmassesincandidatesforassistedreproductivetherapy |